Israel’s largest healthcare provider on Sunday reported a 94 percent drop in symptomatic Covid-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.

Health maintenance organization (HMO) Clalit, which covers more than half of all Israelis, said the same group was also 92 percent less likely to develop severe illness from the virus...